Skip to main content

Home/ Cancer/ Group items tagged Celebra

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cuta... - 0 views

www3.interscience.wiley.com/...abstract

2008 December study case report_case_report EGFR blocker cetuximab Erbitux COX-2 inhibitor celecoxib Celebrex Celebra combination therapy treatment skin cancer skin_cancer cutaneous SCC recurrent advanced medicine

shared by Matti Narkia on 15 Mar 09 - No Cached
  • Matti Narkia on 15 Mar 09
     
    Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN. J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. English, German. PMID: 19138272 DOI: 10.1111/j.1610-0387.2008.06861.x
Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg... - 0 views

clincancerres.aacrjournals.org/...5930

2004 September study research in_vitro EGFR tyrosine_kinase inhibitors inhibitor inhibition TKI TKIs Iressa gefitinib COX-2 celecoxib Celebre3x Celebra head_and_neck_cancer head_and_neck cancer SCCHN SCC HNCA synergy medicine head neck oncology

shared by Matti Narkia on 15 Mar 09 - Cached
  • Matti Narkia on 15 Mar 09
     
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Clin Cancer Res. 2004 Sep 1;10(17):5930-9. PMID: 15355926
1 - 2 of 2
Showing 20▼ items per page